Endocrine Flashcards
Causes of raised ALP
Osteomalacia Bone mets Pregnancy Hyperparathyroidism Bone fracture Liver: cholestasis, hepatitis, fatty liver, neoplasia Renal failure
Causes of pseudohyponatremia
Taking blood from a drip arm
Hyperlipidaemia (increase in serum volume)
ECG features of hypokalaemia
Prolonged QT interval
Prolonged PR interval
U waves
ECG features of hyperkalaemia
Tall tented T waves
Widening of QRS complex
Small P waves
Causes of hyperkaleamia
Addisons AKI Metabolic acidosis Rhabdomyolysis Massive blood transfusion Drugs: potassium sparing diuretics, ACEi, ARBs, spironolactone, ciclosporin, heparin
Management of hypercalcaemia
IV fluids - huge amounts. 3-4L/day
IV bisphosphonates - take 2-3 days to work with max effects at 7 days. Give after rehydration
Trousseau’s sign
carpopedal spasm caused by
inflating the blood-pressure cuff to a level above the systolic blood pressure in patients with hypocalcaemia
SIADH drug causes
Carbamazepine, sulfonylureas, SSRIs, tricyclics, ecstasy
Metformin
Increases insulin sensitivity
Weight neutral
GI side effects + lactic acidosis
CI if eGFR <30
Skin signs of diabetes
Acanthosis nigricans
Skin tags
Central obesity
Hirsutism
Which 2 DM drugs CI together?
DDP4 inhibitors + GLP-1 R agonists
Dose of metformin
500mg BD increasing to 1000mg BD
Hba1c aim if on dual therapy for DM
53
First intensification of DM treatment
Metformin PLUS
- SU
- Pioglitazone
- SGLT-2
- DPP-4i
Which DM drug is injectable?
GLP-1 R agonist
- Dulaglutide
- Exenatide
Which DM drug is in an incretin?
GLP1-R agonist
- Stimulates insulin release
- Suppresses glucagon
- Inhibits gastric emptying
- Promotes saiety
Who to give GLP1-R agonist to?
Given in combination with metformin + SU to
- BMI >35 where WL would benefit obesity related comorbidities or psychological
- BMI <35 where insulin would lead to occupational restrictions or WL would benefit them
DPP-4i
Gliptins
- Alogliptin
- Linagliptin
- Sitagliptin
SEs = gord + abdo pain
TZDs
Pioglitazone
SEs = hypos, #, increased risk of infection, increased LFTs (check every 8wks for 1yr), weight gain, fluid retention, ankle oedema
CI = stop if ALT >3 fold, HF, bladder Ca, v haematuria
SU
Gliclazide
SEs = weight gain, abdo pain, hypos
SGLT2 inhibitors
Canagliflozin
SEs = UTI, balanoposthitis, thirst, dyslipidaemia
GLP1-R agonist
Dulaglutide
Exenatide
SEs = reduced appetite, GI problems, asthenia CI = GFR <30, ketoacidosis